Business Standard

Wednesday, December 25, 2024 | 12:12 AM ISTEN Hindi

Notification Icon
userprofile IconSearch

Zydus supplies first batch of 30,000 Covid Kavach Elisa tests to ICMR

Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection

Zydus
Premium

The test was validated at two sites in Mumbai and has been found to have high sensitivity and specificity

ANI
The first batch of 30,000 Covid Kavach Elisa tests manufactured by Zydus Diagnostics has been supplied to Indian Council of Medical Research (ICMR) free of cost.

These test kits have been manufactured in technology transfer with ICMR-National Institute of Virology (NIV) of Pune for surveillance purposes, said Zydus Diagnostics (a unit of Cadila Healthcare Ltd) in a statement on Thursday.

Robust antibody tests are critical for surveillance and understanding the proportion of the population exposed to SARS Cov-2 infection. ICMR-NIV has successfully developed an indigenous IgG Elisa test for anti-body detection for Covid-19.

The test was validated at two sites

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in